Counterfeit Drug Detection Device Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Counterfeit Drug Detection Market is Segmented by Technology (Infrared and Near Infrared Spectroscopy, Microfluidic (Benchtop Devices, and Handheld Devices), Rapid Chemical Testing, Raman Spectroscopy, RFID Technology, and Other Technologies), Modality (Benchtop Devices and Handheld Devices), Application (Chemical Composition and Packaging and Labelling Detection), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (USD million) for the above segments.

Counterfeit Drug Detection Device Market Size

Single User License


Team License


Corporate License


Book before:
Counterfeit Drug Detection Device Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 4.10 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Low

Major Players

Counterfeit Drug Detection Device Market Major Players

*Disclaimer: Major Players sorted in no particular order


Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License


Team License


Corporate License


Book before:

Counterfeit Drug Detection Device Market Analysis

The global counterfeit drug detection market is anticipated to witness a CAGR of 4.1% over the forecast period.

The COVID-19 pandemic significantly impacted drug manufacturing companies in its preliminary phase. The governments of several countries reported drugs and active pharmaceutical ingredients (APIs) were in short supply due to the outbreak. This was due to cross-border trade barriers that had an ultimatum effect on the import and export of medicinal products, including drugs, resulting in the rise of counterfeit medicines on the market. As per OECD updates from July 2021, the COVID-19 crisis heightened the dangers posed by the global trade in counterfeit pharmaceutical products. Health and safety issues arose when most of the population ordered falsified medicines online since these often needed to be correctly formulated and contain unsafe ingredients. Thus, tackling this global scourge became even more acute and urgent during the pandemic, boosting the use of several counterfeit drug detection devices. Moreover, as per the analysis, this amplified introduction of counterfeit drugs within the market, along with growing volumes of falsified medicines in developing countries due to a lack of stringent regulatory and standardized processes, augmented the demand for counterfeit drug detection over the post-pandemic phase.

Furthermore, the emphasis on advanced surveillance in the supply chain, the shifting trend from packaging security to on-dosage security, and supportive government legislation are some drivers bolstering the market's growth.

In addition, the rising number of counterfeit drugs is one of the major factors propelling the growth of counterfeit drug detection over the forecast period. Due to the COVID-19 pandemic, counterfeit products increased on the market owing to the crunch in the supply side of drugs. For instance, according to the WHO report, in 2021, the number of cases of substandard and falsified (SF) medical items increased by 52% from 2020. Recently, most incidents involved COVID-19-related medical products, such as vaccines, medicines, COVID test kits, antibiotics, face masks, and sanitizers. In 2021, WHO's surveillance and monitoring system for substandard and counterfeit medical products discovered fraudulent versions of the COVID-19 vaccine COVISHIELD in India and Uganda.

Moreover, a study published in May 2022 in SAGE Journals to describe the law enforcement oversight of falsified drugs by the US FDA from 2016 to 2021 stated that 130 unique enforcement actions were against counterfeiting organizations and individuals. Altogether, 64.6% of enforcement actions implicated counterfeit products marketed and sold over the internet. In 84.6% of activities, counterfeit medicines were sold without a prescription, and in 33.1% activities, the products were marketed as dietary supplements. Sexual dysfunction, anabolic muscle building, benzodiazepines, opioids, stimulants, and dermatologic drugs were the most counterfeited. China was the most predominant country to create counterfeit medicines, followed by India, Turkey, Pakistan, and Russia.

Likewise, pharmaceutical companies are incorporating counterfeit drug detection devices into their supply chains, making them more efficient and enhancing patient safety while saving time and money. For instance, in June 2022, AstraZeneca integrated RFID into its supply chain and had remarkable success dispensing over 30 million RFID-enabled Diprivan syringes.

Thus, these factors mentioned above contribute to the market's growth. However, low awareness about counterfeit drugs will likely limit the market's expansion.

Counterfeit Drug Detection Device Market Trends

This section covers the major market trends shaping the Counterfeit Drug Detection Device Market according to our research experts:

RFID Technology Segment Dominates the Market and is Expected to Continue to do so During the Forecast Period

The pharmaceutical industry uses RFID technologies to increase visibility across the value chain and track falsified drugs. The rising number of counterfeit incidents and drug recalls forced the government to reframe drug quality and take strict measures to make QR codes or RFID tags mandatory on active pharmaceutical ingredients and products due to safety and tracking purposes, which are likely to boost the growth of RFID in drug tracing systems in the coming years.

As per the report released by ASPA in March 2022, instances of substandard and falsified (SF) medical items surged by about 47% between 2020 and 2021, driven by the COVID-19 pandemic. According to an article published by the NCBI, in 2022, Valsartan was recalled due to identified contamination with N-nitroso dimethylamine (NDMA), a potentially cancerogenic substance, resulting from unintended changes in the manufacturing process in China. Valsartan is a long-term medication in patients with high blood pressure and heart diseases, which causes carcinogenic effects.

Similarly, due to nitrosamine impurities, losartan and hydrochlorothiazide were also recalled from the market. Furthermore, the introduction of next-generation RFID tags and readers is being efficiently used by drug manufacturers and wholesalers in the pharmaceutical industry to prevent medical errors and increase the safety of individualized medicinal products. Thus, the rising number of counterfeit drugs and drug recalls increased the demand for using detection technologies in drug tracing and tracking systems in the pharmaceutical industry. Therefore, the market segment is expected to surge over the forecast period.

Counterfeit Drug Detection Device Market - Total Number of Counterfeit Incidents Concerning Pharmaceuticals, Global, 2021

North America is Expected to Hold Significant Market Share in the Forecast Period

North America is anticipated to hold the major market share over the forecast period, owing to the increasing risks from substandard and falsified drugs and stringent regulatory frameworks.

The rising incidence of drug counterfeiting in large pharmaceutical and biopharmaceutical companies is the key factor driving the growth of RFID technology in the market. For instance, in December 2020, Janssen Pharmaceutical was notified that counterfeit SYMTUZA had been distributed to over three pharmacies in the United States. The use of RFID is high in supply chain monitoring for tracking assets in real time. Thus, such instances are likely to drive the growth of counterfeit drug detection devices in the pharmaceutical market in the region. Moreover, as per an article published in May 2022 by the Conversation, counterfeiting operations involved tens of millions of pills, more than 1,000 kg (2,200 lbs) of active ingredient powder in the United States, and hundreds of millions of dollars in sales. Unfortunately, with over 11,000 rogue pharmacy sites selling drugs on the internet, these actions barely scratch the surface. The FDA's Office of Criminal Investigations conducts and coordinates criminal investigations into manufacturers and individuals violating federal drug laws. Overall, in 64.6% of cases, the products were sold over the internet, and in 84.6% of the enforcement actions taken, they were obtained without a prescription.

Moreover, the companies developing and launching RFID technologies and systems contribute to the market's growth. For instance, in October 2020, Sandoz partnered with Kit Check, offering artificial intelligence and radio frequency identification medication management technology. Sandoz introduced two RFID-tagged injectable products in the United States under this partnership.

Thus, the market is expected to witness significant growth during the forecast period due to the abovementioned factors.

Counterfeit Drug Detection Market - Growth Rate by Region

Counterfeit Drug Detection Device Industry Overview

The market for counterfeit drug detection is highly fragmented in nature and consists of several global and local players. The major players include Bayer AG, Thermo Fisher Scientific Inc., Spectral Engines Oy, GAO Group, and Systech International. The competitive rivalry is moderate to high due to a small number of regional players. This factor is anticipated to increase the competition for a consolidated customer base. These companies are actively involved in product innovations and technological advancements to sustain their position in the market.

Counterfeit Drug Detection Device Market Leaders

  1. Bayer AG

  2. GAO Group

  3. Systech International

  4. Spectral Engines Oy 

  5. Thermo Fisher Scientific Inc.

*Disclaimer: Major Players sorted in no particular order

Counterfeit Drug Detection Device Market Concentration
Need More Details on Market Players and Competitors?
Download PDF

Counterfeit Drug Detection Device Market News

  • In February 2022, Avery Dennison Smartrac launched its AD Minidose U9 RAIN RFID inlay for pharmaceutical applications, unlocking critical RFID value for healthcare, pharmacies, and laboratory asset management.
  • In August 2021, Avery Dennison Corporation acquired Vestcom for an investment of USD 1.45 billion. The acquisition will help the company expand its branded labeling offerings for the retail and consumer packaged goods industries.

Counterfeit Drug Detection Device Market Report - Table of Contents


    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Emphasis on Advanced Surveillance in the Supply Chain

      2. 4.2.2 Shifting Trend from Packaging Security to On-dosage Security

      3. 4.2.3 Supportive Government Legislation

    3. 4.3 Market Restraints

      1. 4.3.1 Low Awareness of Counterfeit Drugs

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 5.1 By Technology

      1. 5.1.1 Infrared and Near Infrared Spectroscopy

      2. 5.1.2 Microfluidic

      3. 5.1.3 Rapid Chemical Testing

      4. 5.1.4 Raman Spectroscopy

      5. 5.1.5 RFID Technology

      6. 5.1.6 Other Technologies

    2. 5.2 By Modality

      1. 5.2.1 Benchtop Devices

      2. 5.2.2 Handheld Devices

    3. 5.3 By Application

      1. 5.3.1 Chemical Composition

      2. 5.3.2 Packaging and Labeling Detection

    4. 5.4 By Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.4.4 Middle East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle East and Africa

      5. 5.4.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Bayer AG

      2. 6.1.2 Consumer Physics Inc.

      3. 6.1.3 GAO Research Inc.

      4. 6.1.4 Konica Minolta Sensing Americas Inc.

      5. 6.1.5 Rigaku Corporation

      6. 6.1.6 Nynomic Group (Spectral Engines Oy)

      7. 6.1.7 Stratio Inc.

      8. 6.1.8 Systech Group Limited

      9. 6.1.9 Thermo Fisher Scientific Inc.

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Counterfeit Drug Detection Device Industry Segmentation

Counterfeit drugs are one of the most significant challenges faced by healthcare institutions and pharmaceutical manufacturers. Counterfeit drugs and medical equipment are available on a large scale, thereby hampering the goodwill of the market. As a result, there emerged a strong demand for efficient detection systems. This led to the introduction of counterfeit drug detection devices on the market. The market is segmented by technology (infrared and near-infrared spectroscopy, microfluidic (benchtop devices, and handheld devices), rapid chemical testing, Raman spectroscopy, RFID technology, and other technologies), modality (benchtop devices and handheld devices), application (chemical composition and packaging and labeling detection), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (USD million) for the above segments. The report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (USD million) for the above segments.

By Technology
Infrared and Near Infrared Spectroscopy
Rapid Chemical Testing
Raman Spectroscopy
RFID Technology
Other Technologies
By Modality
Benchtop Devices
Handheld Devices
By Application
Chemical Composition
Packaging and Labeling Detection
By Geography
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle East and Africa
South Africa
Rest of Middle East and Africa
South America
Rest of South America
Need A Different Region Or Segment?
Customize Now

Counterfeit Drug Detection Device Market Research FAQs

The Counterfeit Drug Detection Device Market is projected to register a CAGR of 4.10% during the forecast period (2024-2029)

Bayer AG , GAO Group , Systech International , Spectral Engines Oy  and Thermo Fisher Scientific Inc. are the major companies operating in the Counterfeit Drug Detection Device Market.

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).

In 2024, the North America accounts for the largest market share in Counterfeit Drug Detection Device Market.

The report covers the Counterfeit Drug Detection Device Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Counterfeit Drug Detection Device Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

Counterfeit Drug Detection Device Industry Report

Statistics for the 2024 Counterfeit Drug Detection Device market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Counterfeit Drug Detection Device analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

Counterfeit Drug Detection Device Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)